Skip to main content
OpenTrials

Clinical trial condition

Respiratory Syncytial Virus Infections

Explore clinical trials studying Respiratory Syncytial Virus Infections. Study availability and eligibility vary by location and protocol.

146 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Syncytial Virus Infections trial results

Completed

A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years

NCT06573281

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Rolling Hills Estates, California, United States
  • GSK Investigational Site Atlanta, Georgia, United States
  • GSK Investigational Site Lenexa, Kansas, United States
  • GSK Investigational Site Omaha, Nebraska, United States
View Trial Details
Completed

A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD)

NCT06614725

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Kanpur, Uttar Pradesh, India
  • GSK Investigational Site Ahmedabad, India
  • GSK Investigational Site Ahmedabad, India
  • GSK Investigational Site Aligarh, India
View all 14 locations
View Trial Details
Completed

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

NCT04288921

Conditions
Infections, Influenza, Human, Mononegavirales Infections, +8 more
Locations
  • MedHelp Urgent Care Birmingham, Alabama, United States
  • Access Medical Center Encinitas, California, United States
  • Madera Family Medical Group Madera, California, United States
  • ImmunoE Health and Research Centennial, Colorado, United States
View all 20 locations
View Trial Details
Completed

A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above

NCT05921903

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Chicago, Illinois, United States
  • GSK Investigational Site Lexington, Kentucky, United States
  • GSK Investigational Site Minneapolis, Minnesota, United States
View all 46 locations
View Trial Details
Completed

A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Respiratory Tract Illness After Administration of RSV OA Vaccine in Adults 60 Years and Older

NCT06551181

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Shanghai, Putuo, China
  • GSK Investigational Site Shanghai, Putuo, China
  • GSK Investigational Site Shanghai, Shanghai Municipality, China
  • GSK Investigational Site Shanghai, China
View all 40 locations
View Trial Details

Related conditions